| Date Filed | Type | Description |
| 08/21/2023 |
4
| PALEKAR ROHAN (CEO) has filed a Form 4 on 89bio, Inc.|
Txns:
| Paid exercise price by delivering 4,501 shares
@ $15.46, valued at
$69.6k
|
|
| 07/05/2023 |
4
| PALEKAR ROHAN (CEO) has filed a Form 4 on 89bio, Inc.|
Txns:
| Granted 33,334 shares
@ $0
Paid exercise price by delivering 16,527 shares
@ $18.95, valued at
$313.2k
|
|
| 06/09/2023 |
4
| PALEKAR ROHAN (Director) has filed a Form 4 on Neoleukin Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $0.79, valued at
$19.8k
|
|
| 06/07/2023 |
4
| PALEKAR ROHAN (CEO) has filed a Form 4 on 89bio, Inc.|
Txns:
| Sold 15,000 shares
@ $20, valued at
$300k
Exercised 15,000 options to buy
@ $1.93, valued at
$29k
|
|
| 06/05/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/04/2023 |
4
| PALEKAR ROHAN (CEO) has filed a Form 4 on 89bio, Inc.|
Txns:
| Granted 33,333 shares
@ $0
Paid exercise price by delivering 15,443 shares
@ $15.23, valued at
$235.2k
|
|
| 03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/07/2023 |
4
| PALEKAR ROHAN (CEO) has filed a Form 4 on 89bio, Inc.|
Txns:
| Paid exercise price by delivering 4,078 shares
@ $13.24, valued at
$54k
|
|
| 09/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/09/2022 |
4
| PALEKAR ROHAN (CEO) has filed a Form 4 on 89bio, Inc.|
Txns:
| Exercised 100,000 options to buy
@ $1.93, valued at
$193k
|
|
| 05/16/2022 |
4
| PALEKAR ROHAN (Director) has filed a Form 4 on Neoleukin Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $1.07, valued at
$26.8k
|
|
| 04/13/2022 |
4
| PALEKAR ROHAN (CEO) has filed a Form 4 on 89bio, Inc.|
Txns:
| Paid exercise price by delivering 4,088 shares
@ $5.23, valued at
$21.4k
|
|
| 03/04/2022 |
4
| PALEKAR ROHAN (Director) has filed a Form 4 on Neoleukin Therapeutics, Inc.|
Txns:
| Granted 50,000 options to buy
@ $2.72, valued at
$136k
|
|
| 03/04/2022 |
3
| PALEKAR ROHAN (Director) has filed a Form 3 on Neoleukin Therapeutics, Inc. |
| 02/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/08/2021 |
4
| PALEKAR ROHAN (CEO) has filed a Form 4 on 89bio, Inc.|
Txns:
| Bought 5,000 shares
@ $17.07, valued at
$85.4k
Bought 2,000 shares
@ $16.25, valued at
$32.5k
|
|
| 02/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/08/2019 |
3
| PALEKAR ROHAN (CEO) has filed a Form 3 on 89bio, Inc. |
| 11/28/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/12/2014 |
4
| PALEKAR ROHAN (SVP & Chief Commercial Officer) has filed a Form 4 on AVANIR PHARMACEUTICALS, INC.|
Txns:
| Granted 59,231 shares
@ $0
Granted 34,825 shares
@ $0 |
|
| 09/17/2014 |
4
| PALEKAR ROHAN (SVP & Chief Commercial Officer) has filed a Form 4 on AVANIR PHARMACEUTICALS, INC.|
Txns:
| Sold 10,000 shares
@ $10, valued at
$100k
Sold 15,000 shares
@ $12.5, valued at
$187.5k
Exercised 25,000 options to buy
@ $3.38, valued at
$84.5k
|
|
| 02/14/2014 |
4
| PALEKAR ROHAN (SVP & Chief Commercial Officer) has filed a Form 4 on AVANIR PHARMACEUTICALS, INC.|
Txns:
| Granted 80,750 shares
@ $0
Granted 43,000 shares
@ $0 |
|
| 12/19/2013 |
4
| PALEKAR ROHAN (SVP & Chief Commercial Officer) has filed a Form 4 on AVANIR PHARMACEUTICALS, INC.|
Txns:
| Bought 10,000 shares
@ $2.8, valued at
$28k
|
|
| 12/17/2013 |
4
| PALEKAR ROHAN (SVP & Chief Commercial Officer) has filed a Form 4 on AVANIR PHARMACEUTICALS, INC.|
Txns:
| Granted 47,500 options to buy
@ $2.84, valued at
$134.9k
|
|
| 11/05/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/19/2012 |
4
| PALEKAR ROHAN (SVP & Chief Commercial Officer) has filed a Form 4 on AVANIR PHARMACEUTICALS, INC.|
Txns:
| Granted 36,844 shares
@ $0
Granted 26,156 shares
@ $0
Granted 56,250 options to buy
@ $2.59, valued at
$145.7k
|
|
| 12/17/2012 |
4
| PALEKAR ROHAN (SVP & Chief Commercial Officer) has filed a Form 4 on AVANIR PHARMACEUTICALS, INC.|
Txns:
| Bought 10,000 shares
@ $2.4598, valued at
$24.6k
|
|
| 11/02/2012 |
4
| PALEKAR ROHAN (SVP & Chief Commercial Officer) has filed a Form 4 on AVANIR PHARMACEUTICALS, INC.|
Txns:
| Granted 20,000 shares
@ $0
Granted 30,000 shares
@ $0
Granted 275,000 options to buy
@ $3.38, valued at
$929.5k
|
|
| 03/26/2012 |
3
| PALEKAR ROHAN (SVP & Chief Commercial Officer) has filed a Form 3 on AVANIR PHARMACEUTICALS, INC. |
| 04/21/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|